208 related articles for article (PubMed ID: 17262796)
1. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective.
Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM
Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796
[TBL] [Abstract][Full Text] [Related]
2. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
4. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001.
Simsir A; Carter W; Elgert P; Cangiarella J
Am J Clin Pathol; 2005 Apr; 123(4):571-5. PubMed ID: 15743742
[TBL] [Abstract][Full Text] [Related]
5. Normal endometrial cells in liquid-based cervical cytology specimens in women aged 40 or older.
Moroney JW; Zahn CM; Heaton RB; Crothers B; Kendall BS; Elkas JC
Gynecol Oncol; 2007 Jun; 105(3):672-6. PubMed ID: 17363044
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older.
Browne TJ; Genest DR; Cibas ES
Am J Clin Pathol; 2005 Dec; 124(6):834-7. PubMed ID: 16416731
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cells identified in cervical cytology in women > or = 40 years of age: criteria for appropriate endometrial evaluation.
Beal HN; Stone J; Beckmann MJ; McAsey ME
Am J Obstet Gynecol; 2007 Jun; 196(6):568.e1-5; discussion 568.e5-6. PubMed ID: 17547898
[TBL] [Abstract][Full Text] [Related]
8. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
Chang A; Sandweiss L; Bose S
Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
[TBL] [Abstract][Full Text] [Related]
9. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
10. Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratory.
Li Z; Gilbert C; Yang H; Zhao C
Am J Clin Pathol; 2012 Jul; 138(1):79-84. PubMed ID: 22706861
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system.
Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE
Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738
[TBL] [Abstract][Full Text] [Related]
12. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
13. Significance of normal endometrial cells detected by cervical cytology.
Cherkis RC; Patten SF; Andrews TJ; Dickinson JC; Patten FW
Obstet Gynecol; 1988 Feb; 71(2):242-4. PubMed ID: 3336559
[TBL] [Abstract][Full Text] [Related]
14. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
Agboola OO; Grunfeld E; Coyle D; Perry GA
CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
[TBL] [Abstract][Full Text] [Related]
15. Significance of atypical endometrial cells detected by cervical cytology.
Cherkis RC; Patten SF; Dickinson JC; Dekanich AS
Obstet Gynecol; 1987 May; 69(5):786-9. PubMed ID: 3574808
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.
Bristow RE; Purinton SC; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL
Gynecol Oncol; 2006 Nov; 103(2):709-13. PubMed ID: 16797686
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cells in cervical cytology: review of cytological features and clinical assessment.
Greenspan DL; Cardillo M; Davey DD; Heller DS; Moriarty AT
J Low Genit Tract Dis; 2006 Apr; 10(2):111-22. PubMed ID: 16633242
[TBL] [Abstract][Full Text] [Related]
18. Reporting normal endometrial cells in Pap smears: an outcome appraisal.
Gomez-Fernandez CR; Ganjei-Azar P; Capote-Dishaw J; Averette HE; Nadji M
Gynecol Oncol; 1999 Sep; 74(3):381-4. PubMed ID: 10479497
[TBL] [Abstract][Full Text] [Related]
19. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy.
Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):33-9. PubMed ID: 11277646
[TBL] [Abstract][Full Text] [Related]
20. Glandular cells in vaginal cytology Papanicolaou tests in patients with hysterectomy for endometrial adenocarcinoma.
Steele E; Umar SA; Bomeisl P; Miedler J; Zanotti KM; Wasman JK; Hunt DC; Abdul-Karim FW
Diagn Cytopathol; 2012 Feb; 40(2):138-40. PubMed ID: 20891002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
